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The SARS-CoV-2 pandemic is undermining the ability 
of many advanced healthcare systems worldwide to pro-
vide quality care [1, 2]. COVID-19 is the disease caused 
by infection with SARS-CoV-2, a virus with specific tro-
pism for the lower respiratory tract in the early disease 
stage [3]. Computed tomography scans of patients with 
COVID-19 typically show a diffuse bilateral interstitial 
pneumonia, with asymmetric, patchy lesions distributed 
mainly in the periphery of the lung [4–6]. In the context 
of a pandemic, rapid case identification, classification of 
disease severity and correct treatment allocation are cru-
cial for increasing surge capacity. Overtriage to admis-
sion and to intensive care by clinicians working in the 
department of emergency medicine (ED) will overwhelm 
system capacity. Undertriage can lead to loss of life and 
cross infections. Similarly, selection of those patients 
most likely to respond to specific treatments and deter-
mining the response to treatment in the intensive care 
unit (ICU) can conserve scarce resources. Lung ultra-
sound (LUS) is well known for its feasibility and high 
accuracy when used at the bedside for diagnosing pulmo-
nary diseases [7, 8]. As the most striking manifestation 
of COVID-19 disease is in the pulmonary system, LUS 
performed by a trained and knowledgeable clinician may 
aid precisely in triage, classification of disease severity 
and treatment allocation in both the ED and the ICU. In 
this paper, we describe the use of LUS in treating patients 
with COVID-19.
Case identification and classification of disease 
severity
Pending RT-PCR test results, other patients (or staff) 
may be unnecessarily exposed to those carrying the dis-
ease. Verifying that patients have COVID-19 therefore 
remains the rate-limiting step in patient triage. Alter-
natively, redundant implementation of precautions may 
lead to unnecessary resource consumption. The use of 
LUS in this context could revolutionize patient triage.
The LUS technique described in this paper is detailed 
in the supplementary material (Online Resources Supple-
mentary file 12 LUS_TECHNIQUE.docx and Figure_1-6 
and Video_1-2). The pretest probability of gaining useful 
information from LUS is likely to be highest when the cli-
nician seeks to correlate clinical findings with those seen 
in LUS and knows what information to seek in order to 
do so. COVID-19 presents with not only specific LUS 
signs but also with typical patterns of LUS findings.
LUS signs
The signs seen in the LUS of patients with COVID-19 
are similar to those extensively described in patients 
with other types of pneumonia [7]. These include vari-
ous forms of B-lines, an irregular or fragmented pleural 
line, consolidations, pleural effusions and absence of lung 
sliding (see Online Resources Video_3-10) [9]. The LUS 
of patients with COVID-19 usually shows an explosion of 
multiform vertical artifacts and separate and coalescent 
B-lines. The pleural line may be irregular or fragmented 
as is commonly observed in ARDS. As stated above none 
of these signs is pathognomonic to COVID-19 pneumo-
nia and their presence is variable.
Conversely, a typical artifact that we named “light 
beam” is being observed invariably in most patients 
with pneumonia from COVID-19. This artifact corre-
sponds to the early appearance of “ground glass” altera-
tions typical of the acute disease that may be detected in 
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computed tomography. This broad, lucent, band-shaped, 
vertical artifact moves rapidly with sliding, at times creat-
ing an “on–off” effect as it appears and disappears from 
the screen. The bright artifact typically arises from an 
entirely regular pleural line interspersed within areas 
of normal pattern or with separated B-lines (Online 
Resources Video_5). At times it seems to cover the 
A-lines, concealing them entirely. At other times A-lines 
may still be visualized in the background as it is observed. 
The light beam is observed also in other conditions with 
ground glass alterations. Nevertheless, the importance 
of this sign is given by the contingency of the terrible 
pandemic of COVID-19 that we are experiencing in our 
EDs. A multicenter study in progress is investigating the 
accuracy of this sign. To date, a pilot analysis of a mono-
center series of 100 patients suspected for COVID-19 
revealed the presence of multiple light beams in 48 of the 
49 patients with confirmed disease and pneumonia. The 
same sign was never observed in 12 patients with alterna-
tive pulmonary diagnoses and negative swab test (unpub-
lished data).
LUS Patterns
The LUS findings of patients with COVID-19 are unique 
in both combination and distribution. Therefore, patients 
presenting to the ED may be classified into four broad 
categories based on the presence of specific patterns of 
LUS findings (see Table 1). Patients presenting with the 
pattern described in category A have little or no pul-
monary involvement and are therefore unlikely to have 
COVID-19 disease (i.e., asymptomatic SARS-CoV-2 
carriers or patients with no lung disease). In patients 
Table 1 Categories of probability of the disease based on patterns of LUS findings
Category LUS findings
A-Low probability of COVID-19 disease (normal 
lungs)
Regular sliding
A-lines observed over the whole chest
Absence of significant B-lines (i.e., isolated or limited to the bases of the lungs)
B-Pathological findings on LUS but diagnosis other 
than COVID-19 most likely
Large lobar consolidation with dynamic air bronchograms
Large tissue-like consolidation without bronchograms (obstructive atelectasis)
Large pleural effusion and consolidation with signs of peripheral respiratory re-aeration (compres-
sive atelectasis)
Complex effusion (septated, echoic) and consolidation without signs of re-aeration
Diffuse homogeneous interstitial syndrome with separated B-lines with or without an irregular 
pleural line
Patterns suggestive of specific diagnoses:
Cardiogenic pulmonary edema: diffuse B-lines with symmetric distribution and a tight correlation 
between the severity of B-lines and the severity of respiratory failure (anterior areas involved in 
the most severe conditions); in this case distribution of B-lines is uniform and gravity related; 
extending the sonographic examination to the heart will support the alternative diagnosis
Pulmonary fibrosis and interstitial pneumonia from alternative common viruses: the B-lines pat-
tern has greater spread and there are no or limited “spared areas” (alternating normal A-lines 
pattern)
Chronic fibrosis: diffuse B-lines with clinical severity mismatch and with diffuse irregularity of the 
pleural line
C-Intermediate probability of COVID-19 disease Small, very irregular consolidations at the two bases without effusion or with very limited 
anechoic effusion
Focal unilateral interstitial syndrome (multiple separated and/or coalescent B-lines) with or with-
out irregular pleural line
Bilateral focal areas of interstitial syndrome with well-separated B-lines with or without small 
consolidations
D-High probability of COVID-19 disease Bilateral, patchy distribution of multiple cluster areas with the light beam sign, alternating with 
areas with multiple separated and coalescent B-lines and well-demarcated separation from 
large “spared” areas
The pleural line can be regular, irregular and fragmented
Sliding is usually preserved in all but severe cases
Multiple small consolidations limited to the periphery of the lungs
A light beam may be visualized below small peripheral consolidations and zones with irregular 
pleural line
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presenting with any of the LUS patterns described in cat-
egory B (Online Resources Video_11-14) alternative diag-
noses should be sought. These patients are most likely to 
have a condition other than COVID-19 causing their pul-
monary disease. Patients presenting with the pattern of 
LUS findings described in category C (Online Resource 
Video_15) may have COVID-19 disease, whereas those 
presenting with the patterns of LUS findings described 
in category D (Online Resources Video_16-21 and Fig-
ure_7-8) probably have COVID-19 disease.
The presence of large consolidations with air bronch-
ograms mainly in the bases of the lungs should always 
raise suspicion of bacterial cross-infection. As noted 
above, LUS findings are always most informative when 
they are interpreted in light of the clinical context; some 
asymptomatic or mildly symptomatic patients may have 
surprisingly impressive high probability  LUS findings. 
Conversely, in our experience, patients with COVID-19 
disease who suffer from severe respiratory failure are not 
likely to have no or mild LUS alterations.
Treatment allocation
There are several ways LUS may be used to determine 
allocation of treatment resources to those patients most 
likely to respond. These include early quantification of 
the severity of lung involvement, periodic assessment 
for the appearance of findings suggestive of atelectasis 
or pneumonia and monitoring the effects of changes in 
mechanical ventilation and recruitment maneuvers on 
lung aeration.
The use of LUS to quantify and monitor changes in 
aeration has been described in critically ill patients with 
ARDS [10, 11]. It is our impression that, contrary to 
what has been described in ARDS, interstitial patterns 
and consolidations contribute almost equally to lack of 
aeration in patients with COVID-19 [12]. Rather, the 
severity of respiratory impairment seems to be related 
to the overall proportion of lung tissue showing ground-
glass alterations [6]. Early quantification of the severity 
of lung involvement in patients with COVID-19 may be 
obtained by estimating the overall amount of lung areas 
detected as being pathological with ultrasound. Docu-
menting the ultrasound images obtained enables later 
assessment of lesion size and more precise calculation 
of the proportion of diseased lung. The diseased lung 
is identified by the presence of any pathological finding 
(e.g., separated and coalescent B-lines, light beams, con-
solidations) and the areas of diseased lung are measured. 
For each video clip, the proportion of involved lung is 
estimated (0–30-50-70-100%) and the overall proportion 
is then calculated. This method of semi-quantification 
may be used to estimate the extent of lung involve-
ment which could serve to identify at least some of the 
patients more likely to require invasive ventilation.
Periodic assessment for the appearance of findings 
suggestive of atelectasis or pneumonia can be highly 
informative. Identification of interstitial patterns or 
consolidations typical of pneumonia in patients with 
COVID-19 should lead to a change in care. Modify-
ing ventilation parameters is simple but may not suf-
fice for recruitment. We are adopting pronation guided 
mainly by LUS detection of extended lesions in the dor-
sal areas both in patients treated with continuous posi-
tive airway pressure (CPAP) and in invasively ventilated 
patients.
In patients that are invasively ventilated we suggest 
following evidence-based suggestions for monitoring 
aeration changes [10, 11]. The lung is studied in oblique 
scans in two anterior, two lateral and two posterior areas 
per side. Each area is assigned a score ranging from 0 to 
3 (0 = normal A-lines, 1 = multiple separated B-lines, 
2 = coalescent B-lines or light beam, 3 = consolidation). 
The sum of all the areas represents the aeration score. The 
dynamic changes in aeration can then be quantified by 
reassigning a new score to re-aerated areas (see Table 2). 
New methods for automated computer-aided measure-
ment of aeration could be considered when available, 
with the advantage of a more standardized quantitative 
approach for monitoring [13].
Table 2 Quantification of re-aeration and loss of aeration by the observation of changes of the LUS pattern in each of the 
12 chest areas. The final score is the sum of the 12 areas
B1: multiple separated B-lines; B2: coalescent B-lines or light beam; C: consolidation
Re-aeration score Loss of aeration score
 + 1 point  + 3 points + 5 points − 5 points − 3 points − 1 point
B1 to Normal B2 to Normal C to Normal Normal to C Normal to B2 Normal to B1
B2 to B1 C to B1 B1 to C B1 to B2
C to B2 B2 to C
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In the setting of critically ill COVID-19 patients with 
severe pneumonia, the possibility of thromboembolic 
disease should be considered [14]. Even if there are no 
published studies thus far, COVID-19 patients are likely 
at increased risk for thromboembolism [15]. Critically ill 
patients should be treated accordingly and monitored by 
cardiac and venous ultrasound to diagnose deep venous 
thrombosis and cardiac signs of acute pulmonary embo-
lism [16]. We show a case of COVID-19 with sudden 
deterioration and cardiac arrest due to acute pulmonary 
embolism with popliteal thrombosis (Online Resources 
Video_22-23).
Hospital flooding of patients with COVID-19 
imposes a huge burden on the medical system. This 
burden can be somewhat mitigated with optimiza-
tion of patient identification, triage and management. 
LUS is noninvasive and can be performed very rapidly. 
LUS may be used in the ED to identify likely COVID-
19 patients and to identify those patients with more 
extensive pulmonary involvement who should prob-
ably be referred to the ICU. It may serve to differentiate 
between patients with acute signs of respiratory fail-
ure, patients with mild symptoms and normal respira-
tory function, patients with preexisting chronic cardiac 
or pulmonary diseases (see flow charts in Online 
Resources Figure_9-11). In the ICU, LUS may be used 
to identify areas of poor lung aeration and to monitor 
the effect of changes in ventilation and recruitment 
maneuvers on lung aeration.
Electronic supplementary material
The online version of this article (https ://doi.org/10.1007/s0013 4-020-06048 -9) 
contains supplementary material, which is available to authorized users.
Author details
1 Department of Emergency Medicine, San Luigi Gonzaga University Hospital, 
Torino, Italy. 2 Emergency Department and Pre-Hospital Medicine, Valle 
D’Aosta General Hospital, Aosta, Italy. 3 School of Medicine, Universidad Fran-
cisco de Vitoria, Madrid, Spain. 
Acknowledgements
We sincerely thank Prof. Sharon Einav (General Intensive Care, Shaare Zedek 
Medical Centre and Hebrew University Faculty of Medicine, Jerusalem, Israel) 
for her fundamental contribution to the general revision of the manuscript 
and final editing. All the ultrasound videos in the section Online Resources 
have been recorded in the ED and ICU of San Luigi Gonzaga University 
Hospital. We thank the staff nurses and physicians who helped the collection 
of data. We thank the patients who gave their consent to publish the material. 
We thank Dr. Ana Vieira (Department of Nephrology, Santa Casa de Misericór-
dia de Barbacena and University of Medicine of Barbacena, Department of 
Point of Care Ultrasound, Minas Gerais, Brazil) for her valuable contribution in 
the design of the Figures in the section Online Resources.
Authors’ contribution
Luna Gargani, MD, Institute of Clinical Physiology, National Research Council, 
Pisa, Italy. Enrico Storti, MD, Department of Anesthesia and Intensive Care Unit, 
Maggiore Hospital, Lodi, Italy. Dr. Gargani and Dr. Storti contributed actively 
to the conception of this manuscript, sharing their experience with COVID-19 
patients and their expertise in lung ultrasound.
Compliance with ethical standards
Conflicts of interest
Authors declare no conflict of interest with the subject matter.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
Received: 28 March 2020   Accepted: 8 April 2020
Published online: 4 May 2020
References
 1. Xie J, Tong Z, Guan X et al (2020) Critical care crisis and some recom-
mendations during the COVID-19 epidemic in China. Intensive Care Med. 
https ://doi.org/10.1007/s0013 4-020-05979 -7
 2. Arabi YM, Murthy S, Webb S (2020) COVID-19: a novel coronavirus 
and a novel challenge for critical care. Intensive Care Med. https ://doi.
org/10.1007/s0013 4-020-05955 -1
 3. Phelan AL, Katz R, Gostin LO (2020) The novel Coronavirus originating in 
Wuhan, China: challenges for global health governance. JAMA. https ://
doi.org/10.1001/jama.2020.1097
 4. Wu J, Wu X, Zeng W et al (2020) Chest CT findings in patients with corona 
virus disease 2019 and its relationship with clinical features. Invest Radiol. 
https ://doi.org/10.1097/RLI.00000 00000 00067 0
 5. Zhao W, Zhong Z, Xie X, Yu Q, Liu J (2020) Relation between chest CT 
findings and clinical conditions of coronavirus disease (COVID-19) 
pneumonia: a multicenter study. AJR Am J Roentgenol. https ://doi.
org/10.1097/RLI.00000 00000 00067 0
 6. Zhou S, Wang Y, Zhu T, Xia L (2020) CT features of coronavirus disease 
2019 (COVID-19) pneumonia in 62 patients in Wuhan, China. AJR Am J 
Roentgenol China. https ://doi.org/10.2214/AJR.20.22975 
 7. Volpicelli G, Elbarbary M, Blaivas M et al (2012) International evidence-
based recommendations for point-of-care lung ultrasound. Intensive 
Care Med 38(4):577–591
 8. Nazerian P, Volpicelli G, Vanni S et al (2015) Accuracy of lung ultrasound 
for the diagnosis of consolidations when compared to chest computed 
tomography. Am J Emerg Med 33(5):620–625
 9. Peng Q, Wang X, Zhang L (2020) Findings of lung ultrasonography of 
novel corona virus pneumonia during the 2019–2020 epidemic. Intensive 
Care Med. https ://doi.org/10.1007/s0013 4-020-05996 -6
 10. Bouhemad B, Brisson H, Le-Guen M, Arbelot C, Lu Q, Rouby JJ (2011) Bed-
side ultrasound assessment of positive end-expiratory pressure-induced 
lung recruitment. Am J Respir Crit Care Med 183(3):341–347
 11. Mongodi S, Via G, Girard M et al (2016) Lung ultrasound for early diagno-
sis of ventilator-associated pneumonia. Chest 149(4):969–980
 12. Gattinoni L, Chiumello D, Caironi P et al (2020) COVID-19 pneumonia: 
different respiratory treatment for different phenotypes? Intensive Care 
Med. https ://doi.org/10.1007/s0013 4-020-06033 -2
 13. Brusasco C, Santori G, Bruzzo E et al (2019) Quantitative lung ultrasonog-
raphy: a putative new algorithm for automatic detection and quantifica-
tion of B-lines. Crit Care 23(1):288
 14. Tavazzi G, Civardi L, Caneva L, Mongodi S, Mojoli F (2020) Thrombotic 
events in SARS-Cov 2 patients: an urgent call for ultrasound screening. 
Intensive Care Med. https ://doi.org/10.1007/s0013 4-020-06040 -3
 15. Driggin E, Madhavan MV, Bikdeli B et al (2020) Cardiovascular considera-
tions for patients, health care workers, and healthsystems during the 
coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol. https 
://doi.org/10.1016/j.jacc.2020.03.031
 16. Nazerian P, Volpicelli G, Gigli C, Lamorte A, Grifoni S, Vanni S (2018) 
Diagnostic accuracy of focused cardiac and venous ultrasound examina-
tions in patients with shock and suspected pulmonary embolism. Intern 
Emerg Med 13(4):567–574
